Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.42 USD | +0.33% | +0.09% | -3.57% |
05:51pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
05:01pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVN Stock
- NVS Stock
- Revisions Novartis AG